A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs

Shannon R. Matzinger, Tanja Opriessnig, Chao Ting Xiao, Nicholas Catanzaro, Nathan M. Beach, David E. Slade, Gregory P. Nitzel, Xiang Jin Meng

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Porcine circovirus type 2 (PCV2) is the primary causative agent of porcine circovirus-associated disease (PCVAD). Available commercial vaccines all target PCV2a subtype, although the circulating predominant subtype worldwide is PCV2b, and the emerging PCV2d subtype is also increasingly associated with PCVAD. Here we molecularly bred genetically-divergent strains representing PCV2a, PCV2b, PCV2c, PCV2d, and “divergent PCV2a” subtypes by DNA-shuffling of the capsid genes to produce a chimeric virus representing PCV2 global genetic diversity. When placed in the PCV2a backbone, one chimeric virus (PCV2-3cl14) induced higher neutralizing antibody titers against different PCV2 subtypes. Subsequently, a candidate vaccine (PCV1-3cl14) was produced by cloning the shuffled 3cl14 capsid into the backbone of the non-pathogenic PCV1. A vaccine efficacy study revealed that chimeric virus PCV1-3cl14 induces protective immunity against challenge with PCV2b or PCV2d in pigs. The chimeric PCV1-3cl14 virus is a strong candidate for a novel vaccine in pigs infected with variable PCV2 strains.

Original languageEnglish (US)
Pages (from-to)82-93
Number of pages12
JournalVirology
Volume498
DOIs
StatePublished - Nov 1 2016
Externally publishedYes

Fingerprint

DNA Shuffling
Circovirus
Capsid
Immunity
Swine
Viruses
Genes
Vaccines
Neutralizing Antibodies
Organism Cloning

Keywords

  • Capsid
  • DNA shuffling
  • Porcine circovirus type 2 (PCV2)
  • Porcine circovirus-associated disease (PCVAD)
  • Vaccine

ASJC Scopus subject areas

  • Medicine(all)
  • Virology

Cite this

A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs. / Matzinger, Shannon R.; Opriessnig, Tanja; Xiao, Chao Ting; Catanzaro, Nicholas; Beach, Nathan M.; Slade, David E.; Nitzel, Gregory P.; Meng, Xiang Jin.

In: Virology, Vol. 498, 01.11.2016, p. 82-93.

Research output: Contribution to journalArticle

Matzinger, Shannon R. ; Opriessnig, Tanja ; Xiao, Chao Ting ; Catanzaro, Nicholas ; Beach, Nathan M. ; Slade, David E. ; Nitzel, Gregory P. ; Meng, Xiang Jin. / A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs. In: Virology. 2016 ; Vol. 498. pp. 82-93.
@article{389edd5adfed4a1faa12e166f4a4da1f,
title = "A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs",
abstract = "Porcine circovirus type 2 (PCV2) is the primary causative agent of porcine circovirus-associated disease (PCVAD). Available commercial vaccines all target PCV2a subtype, although the circulating predominant subtype worldwide is PCV2b, and the emerging PCV2d subtype is also increasingly associated with PCVAD. Here we molecularly bred genetically-divergent strains representing PCV2a, PCV2b, PCV2c, PCV2d, and “divergent PCV2a” subtypes by DNA-shuffling of the capsid genes to produce a chimeric virus representing PCV2 global genetic diversity. When placed in the PCV2a backbone, one chimeric virus (PCV2-3cl14) induced higher neutralizing antibody titers against different PCV2 subtypes. Subsequently, a candidate vaccine (PCV1-3cl14) was produced by cloning the shuffled 3cl14 capsid into the backbone of the non-pathogenic PCV1. A vaccine efficacy study revealed that chimeric virus PCV1-3cl14 induces protective immunity against challenge with PCV2b or PCV2d in pigs. The chimeric PCV1-3cl14 virus is a strong candidate for a novel vaccine in pigs infected with variable PCV2 strains.",
keywords = "Capsid, DNA shuffling, Porcine circovirus type 2 (PCV2), Porcine circovirus-associated disease (PCVAD), Vaccine",
author = "Matzinger, {Shannon R.} and Tanja Opriessnig and Xiao, {Chao Ting} and Nicholas Catanzaro and Beach, {Nathan M.} and Slade, {David E.} and Nitzel, {Gregory P.} and Meng, {Xiang Jin}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.virol.2016.08.011",
language = "English (US)",
volume = "498",
pages = "82--93",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs

AU - Matzinger, Shannon R.

AU - Opriessnig, Tanja

AU - Xiao, Chao Ting

AU - Catanzaro, Nicholas

AU - Beach, Nathan M.

AU - Slade, David E.

AU - Nitzel, Gregory P.

AU - Meng, Xiang Jin

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Porcine circovirus type 2 (PCV2) is the primary causative agent of porcine circovirus-associated disease (PCVAD). Available commercial vaccines all target PCV2a subtype, although the circulating predominant subtype worldwide is PCV2b, and the emerging PCV2d subtype is also increasingly associated with PCVAD. Here we molecularly bred genetically-divergent strains representing PCV2a, PCV2b, PCV2c, PCV2d, and “divergent PCV2a” subtypes by DNA-shuffling of the capsid genes to produce a chimeric virus representing PCV2 global genetic diversity. When placed in the PCV2a backbone, one chimeric virus (PCV2-3cl14) induced higher neutralizing antibody titers against different PCV2 subtypes. Subsequently, a candidate vaccine (PCV1-3cl14) was produced by cloning the shuffled 3cl14 capsid into the backbone of the non-pathogenic PCV1. A vaccine efficacy study revealed that chimeric virus PCV1-3cl14 induces protective immunity against challenge with PCV2b or PCV2d in pigs. The chimeric PCV1-3cl14 virus is a strong candidate for a novel vaccine in pigs infected with variable PCV2 strains.

AB - Porcine circovirus type 2 (PCV2) is the primary causative agent of porcine circovirus-associated disease (PCVAD). Available commercial vaccines all target PCV2a subtype, although the circulating predominant subtype worldwide is PCV2b, and the emerging PCV2d subtype is also increasingly associated with PCVAD. Here we molecularly bred genetically-divergent strains representing PCV2a, PCV2b, PCV2c, PCV2d, and “divergent PCV2a” subtypes by DNA-shuffling of the capsid genes to produce a chimeric virus representing PCV2 global genetic diversity. When placed in the PCV2a backbone, one chimeric virus (PCV2-3cl14) induced higher neutralizing antibody titers against different PCV2 subtypes. Subsequently, a candidate vaccine (PCV1-3cl14) was produced by cloning the shuffled 3cl14 capsid into the backbone of the non-pathogenic PCV1. A vaccine efficacy study revealed that chimeric virus PCV1-3cl14 induces protective immunity against challenge with PCV2b or PCV2d in pigs. The chimeric PCV1-3cl14 virus is a strong candidate for a novel vaccine in pigs infected with variable PCV2 strains.

KW - Capsid

KW - DNA shuffling

KW - Porcine circovirus type 2 (PCV2)

KW - Porcine circovirus-associated disease (PCVAD)

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84983542593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983542593&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2016.08.011

DO - 10.1016/j.virol.2016.08.011

M3 - Article

AN - SCOPUS:84983542593

VL - 498

SP - 82

EP - 93

JO - Virology

JF - Virology

SN - 0042-6822

ER -